Research Use Only - Important Disclaimer
All products listed on this website are intended for laboratory research use only and are not for human consumption, medical, veterinary, or household use. These products should only be handled by qualified professionals. We do not provide any dosage information, and the products must not be used as food additives, drugs, cosmetics, or for any other inappropriate applications. By purchasing, you acknowledge and agree to these terms.
Tirz GLP-2
Dual GIP and GLP-1 Receptor Agonist
Tirzepatide is a novel investigational peptide that acts as a dual agonist of GIP and GLP-1 receptors, enhancing insulin secretion and improving glycemic control while reducing appetite.
Usage:
Primarily studied in the treatment of Type 2 diabetes and obesity. Research also explores its cardiovascular and metabolic benefits.
Mechanism of Action:
Activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors to regulate blood sugar and appetite.
Benefits:
- Improved insulin sensitivity
- Appetite suppression
- Significant weight loss
- Better glycemic control
Side Effects:
- Nausea
- Vomiting
- Constipation
- Fatigue (in early dosing phase)
Suggested Dosage:
Not specified
Half-life: 5 days
Delivery: Subcutaneous injection